Literature DB >> 33635363

Urine osmolality predicts calcium-oxalate crystallization risk in patients with recurrent urolithiasis.

Stavros A Kavouras1, Hyun-Gyu Suh2, Marion Vallet3, Michel Daudon4, Andy Mauromoustakos5, Mariacristina Vecchio6, Ivan Tack7.   

Abstract

Our aim was to investigate the validity of osmolality from 24-h urine collection in examining the risk for calcium-oxalate (CaOx) kidney stone formation in patients with recurrent urolithiasis. Three hundred and twelve subjects (males/females: 184/128) from France with a history of recurrent kidney stones from confirmed or putative CaOx origin were retrospectively included in the study (46 ± 14 years, BMI: 25.3 ± 5.0 kg·m-2). Tiselius' crystallization risk index (CRI) was calculated based on urinary calcium, oxalate, citrate, magnesium, and volume from 24-h samples. The diagnostic ability of 24-h urine osmolality to classify patients as high risk for kidney stone crystallization was examined through the receivers operating characteristics analysis. High risk for CaOx crystallization was defined as CRI > 1.61 and > 1.18, for males and females, respectively. The accuracy of urine osmolality to diagnose risk of CaOx stone formation (AUC, area under the curve) for females was 84.6%, with cut-off point of 501 mmol·kg-1 (sensitivity: 83.3%, specificity: 76.0%). Males had AUC of 85.8% with threshold of 577 mmo·kg-1 (sensitivity: 85.5%, specificity: 77.6%). A negative association was found between 24-h urine volume and osmolality (r = - 0.63, P < 0.001). Also, a positive association was found between 24-h urine osmolality and CRI (r = 0.65, P < 0.001), as well as urea excretion with CRI (r = 0.37, P < 0.001). In conclusion, urine osmolality > 501 and > 577 mmol·kg-1, in female and in male, respectively, was associated with a risk for CaOx kidney stone formation in patients with a history of recurrent urolithiasis. Thus, when CaOx origin is confirmed or suspected, 24-h urine osmolality provides a simple way to define individualized target of urine dilution to prevent urine crystallization and stone formation.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Calcium; Crystallization; Kidney stones; Oxalate; Urine volume

Mesh:

Substances:

Year:  2021        PMID: 33635363     DOI: 10.1007/s00240-020-01242-2

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  18 in total

Review 1.  Increasing prevalence of kidney stones in the United States.

Authors:  David S Goldfarb
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 2.  The new epidemiology of nephrolithiasis.

Authors:  Jonathan Shoag; Greg E Tasian; David S Goldfarb; Brian H Eisner
Journal:  Adv Chronic Kidney Dis       Date:  2015-07       Impact factor: 3.620

Review 3.  Impact of fluid intake in the prevention of urinary system diseases: a brief review.

Authors:  Yair Lotan; Michel Daudon; Franck Bruyère; Glenn Talaska; Giovanni Strippoli; Richard J Johnson; Ivan Tack
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-05       Impact factor: 2.894

4.  Medical management of kidney stones: AUA guideline.

Authors:  Margaret S Pearle; David S Goldfarb; Dean G Assimos; Gary Curhan; Cynthia J Denu-Ciocca; Brian R Matlaga; Manoj Monga; Kristina L Penniston; Glenn M Preminger; Thomas M T Turk; James R White
Journal:  J Urol       Date:  2014-05-20       Impact factor: 7.450

5.  Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016.

Authors:  Christian Türk; Thomas Knoll; Christian Seitz; Andreas Skolarikos; Chris Chapple; Sam McClinton
Journal:  Eur Urol       Date:  2016-08-06       Impact factor: 20.096

6.  International comparison of cost effectiveness of medical management strategies for nephrolithiasis.

Authors:  Yair Lotan; Jeffrey A Cadeddu; Margaret S Pearle
Journal:  Urol Res       Date:  2005-05-28

7.  Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.

Authors:  G C Curhan; W C Willett; F E Speizer; M J Stampfer
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

Review 8.  The medicinal use of water in renal disease.

Authors:  Connie J Wang; Jared J Grantham; James B Wetmore
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612

9.  Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II.

Authors:  Gary C Curhan; Walter C Willett; Eric L Knight; Meir J Stampfer
Journal:  Arch Intern Med       Date:  2004-04-26

10.  Kidney stones and the risk for chronic kidney disease.

Authors:  Andrew D Rule; Eric J Bergstralh; L Joseph Melton; Xujian Li; Amy L Weaver; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.